Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study
© 2019 The British Pharmacological Society Aims: Sodium glucose co-transporter-2 inhibitors have been shown to reduce cardiovascular events and heart failure in type 2 diabetic (T2D) patients with high cardiovascular risk. Dipeptidyl peptidase-4 inhibitors showed neutral effects and may increase ris...
Saved in:
Main Authors: | Arintaya Phrommintikul, Wanwarang Wongcharoen, Sirinart Kumfu, Thidarat Jaiwongkam, Siriluck Gunaparn, Siriporn Chattipakorn, Nipon Chattipakorn |
---|---|
Format: | Journal |
Published: |
2019
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064487765&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/65738 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury
by: Pongpan Tanajak, et al.
Published: (2018) -
Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats
by: Wanpitak Pongkan, et al.
Published: (2018) -
Anti–Factor Xa Activity of Fixed-Dose Fondaparinux in Low-Body-Weight Patients With Acute Coronary Syndrome
by: Wanwarang Wongcharoen, et al.
Published: (2020) -
Combination of low-dose testosterone and vildagliptin confers cardioprotection in castrated obese rats
by: Apiwan Arinno, et al.
Published: (2019) -
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury
by: Sarayut Lahnwong, et al.
Published: (2020)